| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 37 |
| 1 | FUROSEMIDE | 37 |
| 2 | ASPIRIN 325 MG | 36 |
| 3 | ASPIRIN 81 MG | 36 |
| 4 | METOPROLOL TARTRATE | 24 |
| 5 | METOPROLOL | 23 |
| 6 | ACETAMINOPHEN | 22 |
| 7 | ADALIMUMAB | 22 |
| 8 | AMBRISENTAN | 22 |
| 9 | BOSENTAN | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EYE HEALTH CAPSULE | 1 | 0.0125 |
| 1 | SPESOLIMAB | 3 | 0.0074 |
| 2 | MIGALASTAT HYDROCHLORIDE | 2 | 0.0036 |
| 3 | ADALIMUMAB-AACF | 1 | 0.0030 |
| 4 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 1 | 0.0021 |
| 5 | BROMOCRIPTINE MESYLATE | 1 | 0.0015 |
| 6 | ELAFIBRANOR | 1 | 0.0011 |
| 7 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0011 |
| 8 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 9 | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 50 |
| 1 | Loop Diuretic [EPC] | 43 |
| 2 | Endothelin Receptor Antagonist [EPC] | 41 |
| 3 | Factor Xa Inhibitor [EPC] | 41 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 37 |
| 5 | beta-Adrenergic Blocker [EPC] | 31 |
| 6 | Corticosteroid [EPC] | 30 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 30 |
| 8 | Benzodiazepine [EPC] | 26 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-36 Receptor Antagonist [EPC] | 3 | 0.0074 |
| 1 | Amino Acid Hypertonic Solution [EPC] | 1 | 0.0063 |
| 2 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 3 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 4 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 5 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 6 | Provitamin D2 Compound [EPC] | 18 | 0.0006 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 9 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 11 | 0.0004 |